Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0478 Transporter Info
Gene Name	SLC8A2
Transporter Name	Sodium/calcium exchanger 2
Gene ID	6543
UniProt ID	Q9UPR5

Post-Translational Modification of This DT
Overview of SLC8A2 Modification Sites with Functional and Structural Information
Sequence	M A P L A L V G V T L L L A A P P C S G A A T P T P S L P P P P A N D S D T S T G G C Q G S Y R C Q P G V L L P V W E P D D P S L G D K A A R A V V Y F V A M V Y M F L G V S I I A D R F M A A I E V I T S K E K E I T I T K A N G E T S V G T V R I W N E T V S N L T L M A L G S S A P E I L L S V I E V C G H N F Q A G E L G P G T I V G S A A F N M F V V I A V C I Y V I P A G E S R K I K H L R V F F V T A S W S I F A Y V W L Y L I L A V F S P G V V Q V W E A L L T L V F F P V C V V F A W M A D K R L L F Y K Y V Y K R Y R T D P R S G I I I G A E G D P P K S I E L D G T F V G A E A P G E L G G L G P G P A E A R E L D A S R R E V I Q I L K D L K Q K H P D K D L E Q L V G I A N Y Y A L L H Q Q K S R A F Y R I Q A T R L M T G A G N V L R R H A A D A S R R A A P A E G A G E D E D D G A S R I F F E P S L Y H C L E N C G S V L L S V T C Q G G E G N S T F Y V D Y R T E D G S A K A G S D Y E Y S E G T L V F K P G E T Q K E L R I G I I D D D I F E E D E H F F V R L L N L R V G D A Q G M F E P D G G G R P K G R L V A P L L A T V T I L D D D H A G I F S F Q D R L L H V S E C M G T V D V R V V R S S G A R G T V R L P Y R T V D G T A R G G G V H Y E D A C G E L E F G D D E T M K T L Q V K I V D D E E Y E K K D N F F I E L G Q P Q W L K R G I S A L L L N Q G D G D R K L T A E E E E A R R I A E M G K P V L G E N C R L E V I I E E S Y D F K N T V D K L I K K T N L A L V I G T H S W R E Q F L E A I T V S A G D E E E E E D G S R E E R L P S C F D Y V M H F L T V F W K V L F A C V P P T E Y C H G W A C F G V S I L V I G L L T A L I G D L A S H F G C T V G L K D S V N A V V F V A L G T S I P D T F A S K V A A L Q D Q C A D A S I G N V T G S N A V N V F L G L G V A W S V A A V Y W A V Q G R P F E V R T G T L A F S V T L F T V F A F V G I A V L L Y R R R P H I G G E L G G P R G P K L A T T A L F L G L W L L Y I L F A S L E A Y C H I R G F
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	34
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC8A2 Asparagine 34 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	817
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC8A2 Asparagine 817 has the potential to affect its expression or activity.
Oxidation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A2			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC8A2 Cystine 49 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A2			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	537
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC8A2 Cystine 537 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC8A2			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	577
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC8A2 Cystine 577 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC8A2			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	657
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC8A2 Cystine 657 has the potential to affect its expression or activity.
Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	349
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Serine 349 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	622
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Serine 622 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	108
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Threonine 108 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A2			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	458
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Threonine 458 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC8A2			[4] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	554
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Threonine 554 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC8A2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	565
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Threonine 565 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A2			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	253
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Tyrosine 253 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A2			[10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A2 Tyrosine 255 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A2			[5] , [11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	111
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC8A2 Lysine 111 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A2			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC8A2 Lysine 320 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NAC2_HUMAN)
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
6	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
7	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
8	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
9	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
10	Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
11	Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics. 2018 Oct;18(20):e1800108.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence